Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

STOCKHOLDERS' EQUITY (Details Narrative)																									1 Months Ended		3 Months Ended	12 Months Ended
STOCKHOLDERS' EQUITY (Details Narrative)	Dec. 18, 2017 $ / shares shares	Nov. 13, 2017 USD ($) $ / shares shares	Nov. 05, 2017 $ / shares shares	Sep. 19, 2017 $ / shares shares	Aug. 24, 2017 USD ($) $ / shares shares	Aug. 22, 2017 $ / shares shares	Aug. 21, 2017 $ / shares shares	Jul. 31, 2017 $ / shares shares	Jul. 27, 2017 $ / shares shares	Jul. 26, 2017 $ / shares shares	Jul. 19, 2017 shares	Jul. 14, 2017 shares	Jul. 13, 2017 USD ($) $ / shares shares	May 30, 2017 $ / shares shares	Mar. 31, 2017 $ / shares shares	Feb. 23, 2017 USD ($) $ / shares shares	Jan. 02, 2017 shares	Dec. 29, 2016 USD ($) Investor $ / shares shares	Dec. 21, 2016 USD ($) Investor $ / shares shares	Dec. 06, 2016 $ / shares shares	Nov. 30, 2016 USD ($) Investor $ / shares shares	Oct. 02, 2016 $ / shares shares	Sep. 29, 2016 USD ($) $ / shares shares	Sep. 22, 2016 USD ($) $ / shares shares	Jul. 31, 2017 USD ($) $ / shares shares	Mar. 21, 2017 USD ($) Investor $ / shares shares	Dec. 31, 2017 USD ($) $ / shares shares	Sep. 30, 2017 $ / shares shares	Dec. 31, 2016 USD ($)	Sep. 30, 2016 shares	Sep. 21, 2016 shares	Apr. 05, 2016 shares	Mar. 26, 2013 shares	Dec. 10, 2012 shares	Mar. 22, 2012 shares	Aug. 03, 2006 $ / shares shares
Common stock authorized previously																											515,000,000
Common stock authorized																											250,000,000	500,000,000
Common and preferred stock authorized																											265,000,000	515,000,000
Blank-check preferred stock authorized																											15,000,000	15,000,000
Blank-check preferred stock par value (in dollars per share) \| $ / shares																											$ 0.001	$ 0.001
Common stock issued																											4,360,561	4,299,311			200
Common stock outstanding																											4,360,561	4,299,311			200
Maturity date of the notes																											Sep. 30, 2021
Number of options outstanding																											579,059	554,083
Number of options exercised
Common stock exercise price (in dollars per share) \| $ / shares																											$ 15.24	$ 16.14
Number of stock options granted																											70,000
Total unrecognized stock-based compensation \| $																											$ 1,173,000		$ 474,300
Number of vested shares																											344,934	352,812
Number of unvested shares																											234,125	201,271		65,596
Restricted Stock [Member]
Number of options outstanding																											280,250	222,750
Number of equity instruments other than options outstanding																											280,250	222,750
Common stock exercise price (in dollars per share) \| $ / shares																											$ 5.02	$ 5.31
Number of stock options granted																											57,500
Total unrecognized stock-based compensation \| $																											$ 209,800
Number of vested shares																											219,021	168,021
Number of unvested shares																											61,229	54,729
Number of shares granted under the plan																											57,500
Stock Option [Member]
Total unrecognized stock-based compensation \| $																											$ 963,200		$ 474,300
2006 Stock Incentive Plan [Member]
Common stock outstanding																											1,513
Number of shares reserved for future issuance																																				3,339
Number of options exercised																											0
2012 Omnibus Incentive Compensation Plan [Member]
Common stock purchase price (in dollars per share) \| $ / shares							$ 0.001
Common stock authorized previously							550,000
Common stock authorized							975,000
Weighted exercise price of awarded shares (in dollars per share) \| $ / shares																											$ 6.64
Aggregate intrinsic value of awarded shares \| $																								$ 720,000
Number of options outstanding																											577,546
Common stock exercise price (in dollars per share) \| $ / shares														$ 6.00										$ 6.00
Number of options authorized																																200,000	75,000	27,500	1,667
Number of authorized shares available for grant previously							885,781
Number of authorized shares available for grant							1,570,248
Maximum number of shares granted to individual							150,000
Number of stock options granted														10,000			50,000
Description of plan terms																								(i) increase the total number of shares of Common Stock available for grant under the 2012 Plan from 200,000 shares to an aggregate of 500,000 shares, (ii) add an "evergreen" provision which, on January 1^st of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31^st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan.
Number of vested shares																												2,000
2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares reserved for future issuance																											117,204
Number of equity instruments other than options outstanding																											280,250
Public Offering [Member]
Stock price (in dollars per share) \| $ / shares								$ 5.25																	$ 5.25
Proceeds from public offering \| $																									$ 8,793,750
Public Offering [Member] \| Common Stock and Warrants [Member]
Proceeds from public offering \| $																									$ 8,790,000
45-day Option Over-Allotment Option [Member]
Number of common stock issued																									251,250
Warrant [Member] \| Pro-Rate Option [Member]
Number of common stock issued													2,539,061
Maturity date of the notes													Jul. 26, 2022
Warrant exercise price (in dollars per share) \| $ / shares													$ 5.25
Number of each warrant called													1
Stock price (in dollars per share) \| $ / shares													$ 6.55
Warrant term													5 years
Fair value of public offering \| $													$ 16,375,394
Fair value, maturity													5 years
Volatility rate													211.60%
Expected dividend rate													0.00%
Risk free interest rate													1.89%
Warrant [Member] \| Public Offering [Member]
Number of common stock issued											134,000														1,675,000
Warrant exercise price (in dollars per share) \| $ / shares								$ 5.25																	$ 5.25
Number of each warrant called								1																	1
Stock price (in dollars per share) \| $ / shares								$ 6.55																	$ 6.55
Warrant term																									5 years
Common Stock [Member] \| Public Offering [Member]
Number of common stock issued																									1,675,000
Maximum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																																				$ 5,760
Maximum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																											$ 600
Minimum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																																				$ 2,400
Minimum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares																											$ 3.60
Six Accredited Investors [Member] \| Private Placement [Member]
Number of common stock issued																					160,000
Proceeds from issuance of private placement \| $																					$ 1,000,000
Shares issued (in dollars per share) \| $ / shares																					$ 6.25
Number of accredited investors \| Investor																					6
Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								40,000
Common stock exercise price (in dollars per share) \| $ / shares							$ 4.16
Number of stock options granted							50,000
Number of restricted common stock		7,500
Mr. Robin L. Smith, M.D [Member] \| Private Placement [Member]
Shares issued (in dollars per share) \| $ / shares																					$ 6.25
John Pappajohn [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Common stock exercise price (in dollars per share) \| $ / shares				$ 3.60
Number of stock options granted				12,000
Number of restricted common stock				12,000
John Pappajohn [Member] \| Private Placement [Member]
Number of common stock issued																		16,000								72,000
Proceeds from issuance of private placement \| $																		$ 100,000								$ 450,000
Shares issued (in dollars per share) \| $ / shares																					6.25
Thomas Tierney (Tierney Family Trust) [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Weighted exercise price of awarded shares (in dollars per share) \| $ / shares																							$ 6.00
Number of awarded shares																							20,000
Aggregate intrinsic value of awarded shares \| $																							$ 120,000
Thomas Tierney (Tierney Family Trust) [Member] \| Private Placement [Member]
Shares issued (in dollars per share) \| $ / shares																					$ 6.25
Fourteen Accredited Investors [Member] \| Private Placement [Member]
Number of common stock issued																			48,000
Proceeds from issuance of private placement \| $																			$ 300,000
Shares issued (in dollars per share) \| $ / shares																			$ 6.25
Number of accredited investors \| Investor																			14
Two Accredited Investors [Member] \| Private Placement [Member]
Number of common stock issued																		32,000
Proceeds from issuance of private placement \| $																		$ 200,000
Shares issued (in dollars per share) \| $ / shares																		$ 6.25
Number of accredited investors \| Investor																		2
Four Accredited Investors [Member] \| Private Placement [Member]
Number of common stock issued																										237,000
Proceeds from issuance of private placement \| $																										$ 1,481,300
Shares issued (in dollars per share) \| $ / shares																										$ 6.25
Number of accredited investors \| Investor																										4
RSJ Private Equity (Michal Votruba) [Member] \| Private Placement [Member]
Number of common stock issued																										160,000
Proceeds from issuance of private placement \| $																										$ 1,000,000
Geoffrey E. Harris [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Common stock exercise price (in dollars per share) \| $ / shares				$ 3.60
Number of stock options granted				18,000
Number of restricted common stock				18,000
Geoffrey E. Harris [Member] \| Private Placement [Member]
Number of common stock issued																										5,000
Proceeds from issuance of private placement \| $																										$ 31,300
Directors and Officers [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								144,000
Mr. George Carpenter [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								32,000
Mr. Donald DAmbrosio [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								32,000
Number of restricted common stock		7,500
Mr. Andrew H. Sassine [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Mr. Zachary McAdoo [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Robert Follman (Follman Family Trust) [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Mr. Michal Votruba [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of awarded shares																								20,000
Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares						$ 4.10		$ 3.81	$ 7.25	$ 4.15												$ 6.00			$ 3.81
Number of stock options granted						5,000		10,000	5,000	5,000												102,000
Dr. Donald D'Ambrosio [Member]
Number of options outstanding															18,000
Common stock exercise price (in dollars per share) \| $ / shares															$ 5.90
Description of vesting rights															(i) the option to purchase 15,000 shares vesting in equal monthly installments over 36 months from March 31, 2017, and (ii) the option to purchase 3,000 shares vesting upon the Company's successful listing of its common stock on a national securities exchange.
Underwriters [Member] \| Warrant [Member] \| 45-day Option Over-Allotment Option [Member]
Number of common stock issued					213,800
Proceeds from issuance of warrants \| $					$ 2,100
Stock price (in dollars per share) \| $ / shares					$ 0.01
David Nash [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares			$ 3.88
Number of stock options granted			20,000
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares		$ 3.96
Number of stock options granted		35,000
Amount of vested shares \| $		$ 2,500,000
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche One [Member]
Number of vested shares		11,667
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Two [Member]
Number of vested shares		11,667
Mr. Plotkin [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Three [Member]
Number of vested shares		11,666
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share) \| $ / shares	$ 3.74
Number of stock options granted	5,000
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche One [Member]
Description of vesting rights	Vest upon achieving individual revenues of $150,000
Number of vested shares	1,000
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Two [Member]
Description of vesting rights	Vest upon achieving individual revenues of $325,000
Number of vested shares	1,000
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Three [Member]
Description of vesting rights	Vest upon achieving individual revenues of $500,000
Number of vested shares	1,000
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Four [Member]
Description of vesting rights	Vest upon achieving individual revenues of $625,000
Number of vested shares	1,000
Three Staff Members [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Tranche Five [Member]
Description of vesting rights	Vest upon achieving individual revenues of $725,000
Number of vested shares	1,000
Mr. George C. Carpenter IV [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of restricted common stock		7,500
Various Employees [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of restricted common stock		15,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member]
Number of common shares purchased																				10,000,000
Agreement term																				30 months
Common stock purchase price (in dollars per share) \| $ / shares																$ 7.25				$ 0.50
Description of purchase notice																				Amount equal to 50,000 shares and the closing sale price of the Company's stock is greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.
Number of common stock issued																20,000
Proceeds from issuance of private placement \| $																$ 145,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Commitment Shares [Member]
Number of common shares purchased																				80,000
Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Maximum [Member]
Number of shares sold per day																				50,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| Stock Option [Member]
Expiration period												10 years
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares granted under the plan												25,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Stock Option [Member]
Number of stock options granted												75,000
Number of option to purchase granted annual award limits												50,000
Management and administrative services agreement [Member] \| Arcadian Telepshyciatry Services LLC, PA [Member]
Initial agreement term (in years)		20 years
Management and administrative services agreement [Member] \| Arcadian Telepshyciatry Services LLC, PC [Member]
Initial agreement term (in years)		20 years